Lymphocyte to Monocyte Ratio and C-Reactive Protein Combination as the Best Simple Predictor of Treatment Response in Cirrhotic Patients with Culture Negative Neutrocytic Ascites
There were statistically significant differences for blood monocyte count, NLR (p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Objectives: The aim of this study was to evaluate the most ideal inflammatory markers for treatment response and to determine a cutoff value that could predict response to treatment for culture negative neutrocytic ascite (CNNA) patients.
📊
Temel Bulgular & Veri:Patients with CNNA were evaluated by taking ascites fluid sampling at the beginning and on the 5th day of treatment.
💡
Sonuç & Katkı:There were statistically significant differences for blood monocyte count, NLR (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Objectives: The aim of this study was to evaluate the most ideal inflammatory markers for treatment response and to determine a cutoff value that could predict response to treatment for culture negative neutrocytic ascite (CNNA) patients. Methods: This is a retrospective cross-sectional case-controlled study. Patients with CNNA were evaluated by taking ascites fluid sampling at the beginning and on the 5th day of treatment. Neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and neutrophil-to-monocyte ratio were calculated. Results: Of the 123 cases with cirrhotic ascites disease, 59 were CCNA and 64 were the control group without ascite-fluid infection. There were statistically significant differences for blood monocyte count, NLR (p
🔖
Bu Makaleye Atıf Yap
Barutcu, S., Yildirim, A. E., Sahin, A., Gulsen, M. T. (2022). Lymphocyte to Monocyte Ratio and C-Reactive Protein Combination as the Best Simple Predictor of Treatment Response in Cirrhotic Patients with Culture Negative Neutrocytic Ascites. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 56 - Sayı: 1, 77–83. https://ajindex.com/articles/594602
Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122–8
Ngamruengphong S, Nugent K, Rakvit A, Parupudi S. Potential preventability of spontaneous bacterial peritonitis. Dig Dis Sci 2011;56:2728–34
Sudulagunta SR, Sodalagunta MB, Bangalore Raja SK, Khorram H, Sepehrar M, Noroozpour Z. Clinical profile and complications of paracentesis in refractory ascites patients with cirrhosis. Gastro- enterology Res 2015;8:228–33
Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Plegu- ezuelo M, et al. Infections in patients with cirrhosis increase mor- tality four-fold and should be used in determining prognosis. Gastroenterology 2010;139:1246–56
Fernández J, Gustot T. Management of bacterial infections in cir- rhosis. J Hepatol 2012;56 Suppl 1:S1–12
Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther 2005;21:525–9
Grabau CM, Crago SF, Hoff LK, Simon JA, Melton CA, Ott BJ, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology 2004;40:484–8
European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decom- pensated cirrhosis. J Hepatol 2018;69:406–60
Runyon BA; AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatol- ogy 2009;49:2087–107
Papp M, Vitalis Z, Altorjay I, Tornai I, Udvardy M, Harsfalvi J, et al. Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections. Liver Int 2012;32:603–11
Suvak B, Torun S, Yildiz H, Sayilir A, Yesil Y, Tas A, et al. Mean platelet volume is a useful indicator of systemic inflammation in cirrhotic patients with ascitic fluid infection. Ann Hepatol 2013;12:294– 300
Abdel-Razik A, Mousa N, Elhammady D, Elhelaly R, Elzehery R, El- baz S, et al. Ascitic fluid calprotectin and serum procalcitonin as accurate diagnostic markers for spontaneous bacterial peritoni- tis. Gut Liver 2016;10:624–31
Gundling F, Schmidtler F, Hapfelmeier A, Schulte B, Schmidt T, Pehl C, et al. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis. Liver Int 2011;31:1406–15
Abdel-Razik A, Mousa N, Elbaz S, Eissa M, Elhelaly R, Eldars W. Di- agnostic utility of in